Amarin (AMRN) To Resume Trading at 7:15AM ET

July 27, 2012 6:55 AM EDT
Amarin Corporation plc (Nasdaq: AMRN) will resume trading at 7:15AM ET following FDA approval of Vascepa for severe hypertriglyceridemia.

Amarin is awaiting a decision from FDA as to whether Vascepa will be granted five-year new chemical entity (NCE) or three-year new product marketing exclusivity.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trading Halts

Add Your Comment